Disability News and Research

RSS

Study highlights impact of health and safety programs on companies' investment value

A study utilizing investment simulations for 17 publicly held companies with strong health or safety programs for employees suggests that employers that invest significantly in health and safety programming can outperform other companies in the marketplace.

7 Jan 2016

$Major bone fracture may increase risk of widespread chronic body pain in later life$

Major bone fracture may increase risk of widespread chronic body pain in later life

Breaking a major bone may increase risk of widespread chronic body pain in later life, a new study has found.

6 Jan 2016

Researchers identify factors that may predict outcomes in pediatric patients with intracranial GSWs

Researchers from Memphis, Tennessee, have examined intracranial gunshot wounds (GSWs) in children and adolescents, and identified nine clinical, laboratory, and radiological factors that were predictive of these patients' outcomes.

5 Jan 2016

$New editorial calls on doctors to individualize treatment decisions based on patients' fracture risk$

New editorial calls on doctors to individualize treatment decisions based on patients' fracture risk

A new editorial published by an International Osteoporosis Foundation Working Group urges physicians to individualize treatment decisions based on their patients' fracture risk, rather than automatically interrupting or stopping bisphosphonate therapy after five or three years.

5 Jan 2016

Children conceived through infertility treatments no more likely to have developmental delays

Children conceived via infertility treatments are no more likely to have a developmental delay than children conceived without such treatments, according to a study by researchers at the National Institutes of Health, the New York State Department of Health and other institutions.

5 Jan 2016

Study: Taking high dose of vitamin D3 safe for people with multiple sclerosis

Taking a high dose of vitamin D3 is safe for people with multiple sclerosis and may help regulate the body's hyperactive immune response, according to a pilot study published by Johns Hopkins physicians in the Dec. 30 online issue of Neurology, the medical journal of the American Academy of Neurology.

31 Dec 2015

Myostatin antibody shows promise in treating age-related decline in muscle mass and power

A proof-of-concept, phase 2 trial by an international research team has found promising results for a myostatin antibody in treating the decline in muscle mass and power associated with aging.

29 Dec 2015

Study: Economic burden of cancer survivors varies by age and cancer site

Survivors of cancer pay thousands of dollars in excess medical expenditures every year, with the excess financial burden varying by age and cancer site, according to a new American Cancer Society study. The study, appearing early online in the Journal of the National Cancer Institute, says targeted efforts will be important to reduce the economic burden of cancer.

29 Dec 2015

Novoron Bioscience receives NIH grant to study novel therapeutic approach for multiple sclerosis

Novoron Bioscience, Inc., a private biotech company dedicated to developing new therapeutics for disorders of the central nervous system, today announced that the company has been awarded a National Institutes of Health grant under the Small Business Innovation Research (SBIR) Program.

22 Dec 2015

New treatment strategy may take pain away

A brain region controlling whether we feel happy or sad, as well as addiction, is remodeled by chronic pain, reports a new Northwestern Medicine study.

22 Dec 2015

Scientists identify genes linked to human intelligence

Scientists from Imperial College London have identified for the first time two clusters of genes linked to human intelligence.

22 Dec 2015

Poor outlook for ICH associated with novel oral anticoagulants

Haematoma expansion, disability and death are common among patients who have intracerebral haemorrhage while taking novel oral anticoagulants, a study in JAMA Neurology shows.

18 Dec 2015

UT Southwestern researchers find potential mechanism to prevent epileptic seizures following TBI

UT Southwestern Medical Center researchers have found that halting production of new neurons in the brain following traumatic brain injury can help reduce resulting epileptic seizures, cognitive decline, and impaired memory.

18 Dec 2015

Cardiff scientists find way to aid recovery, reduce risk of life-threatening infections in brain damaged patients

Cardiff University scientists believe they may have found a way to aid recovery and minimise the risk of life-threatening infections in patients with traumatic brain injuries.

17 Dec 2015

One of every three deaths in the U.S. linked to cardiovascular diseases

One of every three deaths in the U.S. in 2013 were from heart disease, stroke and other cardiovascular diseases, while heart disease and stroke were the No. 1 and No. 2 killers worldwide, according to American Heart Association's 2016 Heart Disease and Stroke Statistics Update.

17 Dec 2015

New funding supports research on new and improved drug treatments for tuberculosis, malaria

University of Toronto and McGill University scientists are leading an international partnership to discover new and improved drug treatments for tuberculosis, malaria and neglected tropical diseases -- thanks to a contribution from Merck Canada Inc., as well as an additional $5 million supplement to a grant from the Bill & Melinda Gates Foundation.

17 Dec 2015

Study points to future treatment for post-stroke damage

A study of rats released today shows that blocking a type of RNA produced by what used to be called "junk DNA" can prevent a significant portion of the neural destruction that follows a stroke. The research points toward a future treatment for post-stroke damage, which is often more extensive than the initial destruction that results when blood to the brain is temporarily shut off.

16 Dec 2015

Researchers test new concept in type 2 diabetes patients going into remission

Remission is well-known as the goal in cancer treatment but scientists are discovering it's also an exciting possibility for those with type 2 diabetes.

16 Dec 2015

Egalet submits NDA for ARYMO ER (morphine sulfate) extended-release tablets

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, announced the company has submitted a new drug application (NDA) for ARYMO ER (morphine sulfate) extended-release tablets for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.

15 Dec 2015

Global Health Impact Index can measure actual impact of drugs worldwide

Billions of dollars have been spent on developing drugs and supplying them around the world, but which companies' drugs are actually making an impact? The Global Health Impact Index, headed by Binghamton University Associate Professor Nicole Hassoun and highlighted in a new article published Friday in PLOS ONE, addresses this issue by ranking pharmaceutical companies based on their drugs' impact on global health.

15 Dec 2015

Disability News and Research

Study highlights impact of health and safety programs on companies' investment value

Major bone fracture may increase risk of widespread chronic body pain in later life

Researchers identify factors that may predict outcomes in pediatric patients with intracranial GSWs

New editorial calls on doctors to individualize treatment decisions based on patients' fracture risk

Children conceived through infertility treatments no more likely to have developmental delays

Study: Taking high dose of vitamin D3 safe for people with multiple sclerosis

Myostatin antibody shows promise in treating age-related decline in muscle mass and power

Study: Economic burden of cancer survivors varies by age and cancer site

Novoron Bioscience receives NIH grant to study novel therapeutic approach for multiple sclerosis

New treatment strategy may take pain away

Scientists identify genes linked to human intelligence

Poor outlook for ICH associated with novel oral anticoagulants

UT Southwestern researchers find potential mechanism to prevent epileptic seizures following TBI

Cardiff scientists find way to aid recovery, reduce risk of life-threatening infections in brain damaged patients

One of every three deaths in the U.S. linked to cardiovascular diseases

New funding supports research on new and improved drug treatments for tuberculosis, malaria

Study points to future treatment for post-stroke damage

Researchers test new concept in type 2 diabetes patients going into remission

Egalet submits NDA for ARYMO ER (morphine sulfate) extended-release tablets

Global Health Impact Index can measure actual impact of drugs worldwide

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News